Living donor liver transplantation for patients with alcoholic liver disease
Korean Journal of Hepato-Biliary-Pancreatic Surgery
; : 14-20, 2013.
Article
在 En
| WPRIM
| ID: wpr-103777
Responsible library:
WPRO
ABSTRACT
BACKGROUNDS/AIMS:
Since most transplantation studies for alcoholic liver disease (ALD) were performed on deceased donor liver transplantation, little was known following living donor liver transplantation (LDLT).METHODS:
The clinical outcome of 18 ALD patients who underwent LDLT from Febraury 1997 to December 2004 in a large-volume liver transplantation center was assessed retrospectively.RESULTS:
The model for end-stage liver disease score was 23+/-11, and mean pretransplant abstinence period was 16+/-13 months, with 14 (77.8%) patients being abstinent for at least 6 months. Graft types were right lobe grafts in 11, left lobe grafts in 2 and dual grafts in 5. Graft to recipient body weight ratio was 0.94+/-0.16. The relapse rates in patients who did and did not maintain 6 months of abstinence were 7.1% and 50%, respectively (p=0.097). Younger recipient age was a significant risk factor for alcohol relapse (p=0.027). Five recipients with antibody to hepatitis B surface antigen (HBsAg) received core antibody-positive liver graft, but two of them showed positive HBsAg seroconversion. Overall 5-year patient survival rate following LDLT was 87.8%, with a 5-year relapse rate of 16.7%.CONCLUSIONS:
Pretransplant abstinence for 6 months appears to be benefical for preventing posttransplant relapse. Life-long prophylactic measure should be followed after use of anti-HBc-positive liver grafts regardless of hepatitis B viral marker status of the recipient.Key words
全文:
1
索引:
WPRIM
主要主题:
Recurrence
/
Tissue Donors
/
Body Weight
/
Biomarkers
/
Survival Rate
/
Risk Factors
/
Liver Transplantation
/
Living Donors
/
Transplants
/
Alcoholics
研究类型:
Etiology_studies
/
Prognostic_studies
/
Risk_factors_studies
限制:
Humans
语言:
En
期刊:
Korean Journal of Hepato-Biliary-Pancreatic Surgery
年:
2013
类型:
Article